Researchers at Barts Cancer Institute reveal promising acute myeloid leukaemia treatment targeting fat metabolism, addressing the urgent need for better therapies.
We recently welcomed a group of 16 cancer patient advocates into our labs for the 11th edition of our VOICE science for advocates course, co-run with the charity Independent Cancer Patients’ Voice.
Researchers from Barts Cancer Institute, Queen Mary University of London are part of a nationwide team of universities, hospitals and industry collaborating on a new platform to understand immunotherapy response and side effects in cancer.